Literature DB >> 8298935

Surgical management of perineal and metastatic cutaneous Crohn's disease.

N Williams1, N A Scott, J S Watson, M H Irving.   

Abstract

Skin lesions are the commonest extraintestinal manifestation of Crohn's disease. Lesions that develop at sites remote from the gastrointestinal tract and have granulomas on histological examination are termed metastatic cutaneous Crohn's disease. Management is difficult as medical treatment is often ineffective. This report describes the use of surgical debridement of areas of perineal metastatic cutaneous Crohn's disease in five patients, all of whom had failed to improve after a variety of medical treatments. One patient had a poor result with continuing mild perineal discharge and four had a good outcome with complete resolution of symptoms and satisfactory cosmetic results.

Entities:  

Mesh:

Year:  1993        PMID: 8298935     DOI: 10.1002/bjs.1800801235

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  5 in total

1.  Metastatic Crohn's disease of the face.

Authors:  Deborah B Graham; David L Jager; Marie L Borum
Journal:  Dig Dis Sci       Date:  2006-09-29       Impact factor: 3.199

Review 2.  Perineal metastatic Crohn's disease: a case report and review of the literature.

Authors:  L H Moyes; P Glen; I R Pickford
Journal:  Ann R Coll Surg Engl       Date:  2007-01       Impact factor: 1.891

Review 3.  Current clinical issue of skin lesions in patients with inflammatory bowel disease.

Authors:  Tomoya Iida; Tokimasa Hida; Minoru Matsuura; Hisashi Uhara; Hiroshi Nakase
Journal:  Clin J Gastroenterol       Date:  2019-03-05

Review 4.  Metastatic Crohn's Disease: An Approach to an Uncommon but Important Cutaneous Disorder.

Authors:  Babak Aberumand; Jessica Howard; John Howard
Journal:  Biomed Res Int       Date:  2017-01-03       Impact factor: 3.411

5.  Metastatic Crohn's disease of external genitalia.

Authors:  Charles Panackel; Joseph John; Devadas Krishnadas; Kattoor R Vinayakumar
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.